Entera Bio: Funding, Investors & Team (Sep 2026)
Entera Bio is using its advanced delivery system to create innovative oral medications. This system effectively shields large molecules and peptides in the gastrointestinal tract. Oral drug delivery is the easiest and most convenient way to administer medical treatment. Entera Bio has a skilled team of experts who possess the necessary expertise, experience, and connections to facilitate the swift development of its products. The company is led by a seasoned management team with over five decades of collective experience in drug development.
Entera Bio has raised $16.6M across 2 funding rounds on record, the most recent an undisclosed round of $10.0M announced in Apr 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Entera Bio Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Entera Bio Funding Rounds
Entera Bio raised $6.6M in an undisclosed round announced in Dec 2023.
2.3 years later, an undisclosed round of $10.0M was announced in Apr 2026.
Entera Bio Founders and Leadership Team
Contact details for the Entera Bio team: 2 of 2 have an email address on file.
Start 14-day free trial →Entera Bio Funding Compared to Other Biotechnology Startups
Entera Bio's latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Entera Bio in Biotechnology and Jerusalem
Companies Similar to Entera Bio
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
Entera Bio Funding FAQs
What does Entera Bio do?
Entera Bio is using its advanced delivery system to create innovative oral medications. This system effectively shields large molecules and peptides in the gastrointestinal tract. Oral drug delivery is the easiest and most convenient way to administer medical treatment. Entera Bio has a skilled team of experts who possess the necessary expertise, experience, and connections to facilitate the swift development of its products. The company is led by a seasoned management team with over five decades of collective experience in drug development.
How much funding has Entera Bio raised?
Entera Bio has raised $16.6M across 2 rounds on record. The most recent is an undisclosed round of $10.0M announced in Apr 2026.
When did Entera Bio last raise funding?
Entera Bio's most recent funding round on record is an undisclosed round of $10.0M, announced in Apr 2026.
Who founded Entera Bio?
FundedIQ lists Hillel Galitzer (Founder), Miranda Toledano (Founder) at Entera Bio.
Where is Entera Bio headquartered?
Entera Bio is based in Jerusalem, Yerushalayim, Israel.
How many employees does Entera Bio have?
Entera Bio is in the 11-50 employee band.
How does Entera Bio's funding compare to other Biotechnology startups?
Entera Bio's latest round of $10.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Entera Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Entera Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.